Atlas Trials

Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Clinical trial NCT05813626 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05813626
Sponsor
Zhejiang Cancer Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2023-04-21
Primary completion
2025-08-15
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.